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The endoplasmic reticulum (ER) is a critical organelle for protein synthesis, protein trafficking, 
and lipid synthesis. As such, cells have evolved a quality control system known as the ER Unfolded 
Protein Response (UPRER). Capable of monitoring protein folding and membrane lipid 
composition to preserve ER homeostasis, the UPRER is crucial for responding to cellular stress 
brought on by increased metabolic demand, environmental factors, and aging. In this study, we 
have identified let-767 as an essential gene for ER homeostasis. Through an RNAi screen of lipid 
droplet associated genes, we found that knockdown of let-767 resulted in reduced lipid droplets, 
aberrant ER morphology, and compromised UPRER induction, which impacted growth and 
lifespan. We found that these deficiencies in ER quality were independent of let-767’s previously 
characterized function in mono-methyl branched chain fatty acid synthesis (mmBCFAs), as 
supplementation of mmBCFAs did not ameliorate the detrimental phenotypes. However, 
supplementation of whole animal lysate was able to rescue the lipid droplet depletion, ER 
morphology, and animal growth, but not the UPRER function. The UPRER induction was instead 
rescued by reducing the let-767 pathway through knockdown of the upstream transcription factor 
sbp-1, suggesting accumulation of a potential toxic metabolite within the let-767 pathway. Our 
results indicate that let-767 may play a more significant role in lipid metabolism than has been 
previously described and highlight the importance of lipid homeostasis to protein quality control.
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Chapter 1: Introduction 
1.1 Cellular Proteostasis and the Endoplasmic Reticulum 
Proteins function in every aspect of the cell, from structural support to carrying out complex 
enzymatic reactions. As such, monitoring and preserving protein quality is vital for cellular 
function. Stable maintenance of proteins and protein complexes in a properly folded and 
assembled state while balancing protein synthesis and turnover is collectively known as protein 
homeostasis, or proteostasis [1]. Central to maintaining this balanced state are chaperones, 
proteins capable of folding and unfolding cellular proteins or binding them to prevent 
aggregation and promoting their clearance [2]. Due to the unpredictable nature of life, cells must 
also be capable of responding to numerous environmental and biological stresses to maintain 
proteostasis and preserve cellular function. 
Within eukaryotic cells, membrane bound organelles carry out specialized tasks requiring 
distinct local environments, adding to the intricacy of maintaining proteostasis. To this end, cells 
have evolved compartment specific systems capable of responding to perturbations in 
proteostasis within the cytoplasmic, mitochondrial, and endoplasmic reticulum (ER) 
compartments. These stress response systems are known as the heat shock response (HSR), 
mitochondrial unfolded protein response (UPRmito), and the endoplasmic reticulum unfolded 
protein response (UPRER), respectively. Upon activation, these systems initiate complex genetic 
programs via key transcription factors: hsf-1 (HSF1, mammalian ortholog), atfs-1 (ATF4, 
mammalian ortholog), and xbp-1 (XBP1, mammalian ortholog), respectively. While all three of 
these genetic programs commonly result in upregulation of chaperones to manage protein 
quality, each stress response also alters compartment specific factors to preserve organelle 
function [3].  
Of the three major unfolded protein responses, the UPRER possesses the most branched input 
mechanism. To maintain proteostasis of the ER, the UPRER incorporates 3 distinct signaling 
transmembrane proteins into its activation: PEK-1 (PERK, human ortholog), ATF-6 (ATF6, 
human ortholog), and IRE-1 (IRE1, human ortholog). Within the ER lumen, these proteins are 
bound by the HSP70 chaperone, HSP-4 (HSP5A/BiP, human ortholog), under basal conditions. 
Upon protein misfolding, HSP-4 is titrated away from them to allow the luminal domains of 
IRE-1 and PEK-1 to interact with misfolded proteins, which induce dimerization and activation 
through transphosphorylation of cytosolic kinase domains. The activated PEK-1 is then able to 
phosphorylate the translation initiation factor EIF2a (EIF2A, human ortholog) to globally reduce 
translation and preferentially translate the transcription factor ATF-5 (ATF4, human ortholog) to 
initiate its stress response. Upon IRE-1’s activation, the cytosolic RNAse domain begins splicing 
xbp-1 mRNA to the much more active xbp-1s isoform, launching its genetic program. IRE-1’s 
activation also results in its oligomerization which promotes regulated IRE1-dependent decay of 
mRNA (RIDD) to further reduce the ER protein load [4]. Uniquely, ATF-6 does not oligomerize 
upon HSP-4 dissociation, but instead is trafficked to the Golgi complex where it is cleaved from 
the membrane and imported into the nucleus to induce expression of stress response genes [5].  
Together, these three sensors and their corresponding transcription factors are responsible for 
maintaining the ER proteostasis and determining a cell’s fate. When proteostasis cannot be 
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maintained, prolonged activation of the UPRER can lead to apoptosis, inflammatory signaling, or 
accumulation of toxic protein species, resulting in impeded cellular function and disease. This 
association between impaired proteostasis and compromised health has been observed in 
numerous chronic conditions, including diabetes, aging, and especially neurodegenerative 
disease. In the case of neurodegenerative disorders, affected individuals exhibit hallmark 
neurological symptoms, but also present with pathological accumulations of intracellular and/or 
extracellular protein aggregates [6]–[8]. Interestingly, these symptoms usually appear later in the 
individual’s life, which coincides with an organism’s increasingly dysfunctional UPRER [9], [10]. 
Whether these aggregates contribute to the disease progression or are merely a symptom of 
global loss of proteostasis is not fully understood [11]. However, ectopic manipulation of the 
stress response pathways has been observed to increase protection from proteotoxic stress and 
increase the median lifespan of model organisms [12]–[14]. As such, these stress pathways are 
very active areas of study with the goal of elucidating unknown factors which regulate or 
influence the regenerative potential of the HSR, UPRmito, and UPRER.  
1.2 Lipid homeostasis and the endoplasmic reticulum 
Much like proteins, lipids play multiple roles within a cell, from being the key component in 
membranes to functioning as signaling or energy storage molecules. These macromolecules exist 
in highly variable molecular structures that can be joined together or modified to form more 
complex lipids with distinct signaling and physical properties from their simpler counterparts. It 
is therefore vital that lipid quantity and composition be monitored to preserve lipid homeostasis 
and prevent lipotoxic accumulation of lipid metabolites. 
Fatty acids and cholesterol are fundamental lipids and integral to membrane quality. As 
components of multiple lipid subtypes such as phospholipids and sphingolipids, fatty acid chain 
lengths, attached head groups, and branched or saturated characteristics can have significant 
effects on membrane dynamics, thickness, and curvature. Additionally, the breakdown of these 
more complex lipid species to diacylglycerol or ceramide, respectively, not only affect 
membrane quality, but also function as strong signaling molecules which can have dramatic 
effects if their quantity is not regulated. Similarly, cholesterol and its metabolites have 
significant effects on membrane fluidity while also serving as precursors for powerful signaling 
molecules known as steroid hormones [15], [16]. To prevent the toxic accumulation of these 
bioactive lipid species, cells can convert sterols and fatty acids into cholesteryl esters, 
triglycerides, or other neutral lipids [17], [18]. These highly hydrophobic molecules lack charged 
groups, making them inert and the preferred lipid storage form of cells. 
Lipids are processed within multiple compartments of a cell; however, specific organelles 
play distinct roles in lipid metabolism. Initial fatty acid synthesis mainly occurs within the 
mitochondria and cytoplasm. These fatty acids are then elongated by the mitochondria, 
cytoplasm, and ER [19], [20]. Mitochondria are also a site of fatty acids catabolism. 
Mitochondria break down fatty acids through beta-oxidation with peroxisomes, which also 
perform alpha-oxidation of branched fatty acids. While peroxisomes can also synthesize complex 
ether lipids, most other lipids such as membrane lipids, cholesterol, and neutral lipids are 
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synthesized by the ER, making the ER a major site of lipid metabolism[21], [22]. As such, the 
ER is a primary source of membrane lipids for multiple organelles. 
Basal lipid metabolism is largely maintained through ligand-activated control of transcription 
factors which regulate multiple enzymes of lipogenic pathways [23]. One such transcription 
factor, the Sterol Regulatory Element-Binding Protein (SREBP), is localized to the ER. SREBP 
is highly conserved from yeast (Mga2 & Sre1) to mammals (SREBP1 & SREBP2) and 
incorporates numerous metabolic cues from insulin, mammalian target of rapamycin (mTOR), 
and downstream lipid products. Similar to ATF6, SREBP activation is dependent on its 
trafficking to the Golgi complex, where it is proteolytically processed and freed to enter the 
nucleus. Once activated, SREBP functions with multiple cofactors to control a variety of lipid 
pathways including cholesterol, fatty acid, and complex lipid synthesis [24].  
As a crucial organelle to lipid homeostasis, the ER has evolved lipid homeostasis sensors. 
Interestingly, these sensors are also the UPRER transmembrane proteins, IRE1, PERK, and 
ATF6. Adjacent to their transmembrane helices, IRE1 and PEK1 contain an amphipathic helix 
capable of sensing general ER membrane imbalances and activating the UPRER independent of 
their luminal unfolded protein sensing domains [25], [26]. Within the transmembrane domain of 
ATF6, a sphingolipid sensing motif triggers ATF6 activation upon accumulation of 
dihydrosphingosine or dihydroceramide, also independent of proteotoxic stress [27]. In 
combination with basal lipid metabolism transcription factors, these proteins play an integral role 
in maintaining lipid homeostasis. 
Utilizing the same stress response sensors for protein and lipid stress results in an undeniable 
link between lipid and ER protein homeostasis. This association is highlighted in individuals 
suffering from obesity. Aside from aberrant lipid storage and regulation, these individuals also 
present with systemic inflammation, a known symptom of chronic ER stress [28], [29]. 
Conversely, ER stress within the brain’s metabolic control center, the hypothalamus, has been 
shown to contribute to metabolic changes that instigate weight gain and insulin resistance in 
mice, hallmark symptoms of obesity [9], [30]. These associations suggest that the UPRER likely 
plays a role in the mechanism of lipotoxicity. Interestingly, individuals in advanced age, with 
likely compromised UPRER activity, also present with many conditions associated with obesity, 
suggesting that UPRER is also crucial for maintaining lipid homeostasis [31]. 
1.3 Lipid droplets and lipid homeostasis 
Conserved from bacteria to humans, lipid droplets are integral to lipid homeostasis. They 
store neutral lipids within a core surrounded by a phospholipid monolayer decorated with 
regulatory and enzymatic proteins. Within eukaryotes, lipid droplets are formed through 
deposition of neutral lipids between the ER membrane leaflets. After stabilization of these 
deposits by various proteins, further deposition of neutral lipids allows for growth and eventual 
release of a mature lipid droplet into the cytosol.  Ranging in size from a few nanometers to 200 
µm within multiple cell types, they function as dynamic hubs for sequestering bioactive 
molecules as neutral lipids, while also providing a means to regulate lipid distribution and 
surplus lipids to maintain lipid homeostasis [17], [32]. 
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Once thought to be inert vesicles of lipids, lipid droplets are now understood to play an active 
role in regulating lipid homeostasis and influencing metabolism. Both enzymatic and regulatory 
proteins are targeted to lipid droplets during their biogenesis and contribute to their growth and 
dynamic characteristics. Acyltransferases allow for triglyceride synthesis and cholesterol 
esterification, while lipases and hydrolases can mobilize neutral lipids into their active 
metabolites [17]. Of the lipid droplet regulatory proteins, the perilipin family is the best 
characterized. They function in stabilization of lipid droplets during biogenesis and regulate 
lipolysis. Under basal conditions, Perilipin 1 limits lipolysis by binding to Comparative Gene 
Identification 58 (CGI-58) to prevent both proteins from associating with lipases. Activation of 
Perilipin 1 through phosphorylation results in its dissociation from CGI-58 and each protein’s 
association with Adipose Triglyceride Lipase (ATGL) and Hormone Sensitive Lipase (HSL), 
respectively, inducing a >50-fold increase in lipolysis [33]. To further regulate the cellular lipid 
pool, cells preferentially funnel lipids through lipid droplets instead of directly to various 
organelles, likely serving as a safeguard against transiently excessive or limiting pools of 
intracellular lipids. The direct interaction between lipid droplets and other organelles then allows 
for improved control over local transfer of lipids during times of need [34], [35]. This interaction 
can also serve as a metabolic cue. In the case of mitochondria, associating with lipid droplets 
results in a metabolic shift distinct from that of unassociated mitochondria [36]. 
An inability to maintain lipid homeostasis results in aberrant lipid accumulation and impaired 
cellular function. These effects are clearly observed in cases of lipodystrophies and obesity. Due 
to congenital defects in lipid storage genes or drug treatments (e.g. antiretroviral therapy), 
individuals with lipodystrophies are unable to effectively store lipids within their adipose tissue, 
cells highly enriched with lipid droplets to specifically store excess lipids. This results in 
aberrant lipid accumulation and often leads to the development of diabetes, hypertriglyceridemia, 
pancreatitis, and hepatic steatosis [37]. Conversely, individuals with obesity can store lipids 
within their adipose tissue but are unable to completely meet the demand due to the excessive 
consumption of lipids. This also results in an ectopic accumulation of lipids and development of 
diabetes, hypertriglyceridemia, and hepatic steatosis, as well as increased risks for heart disease, 
strokes, and kidney disease [38]–[40]. Interestingly, individuals with increased age are also at 
increased risk for these diseases, suggesting a general decline in lipid homeostasis with age [31]. 
As the central organelle for lipid storage, lipid droplet quality is crucial to maintaining lipid 
homeostasis. Expectedly, lipid droplets of obese individuals appear to be compromised in 
regulation and associations. Obese animals have reduced Perilipin 1 on adipose lipid droplets, 
thereby reducing effective control over lipolysis [41]. Within the muscle cells of obese 
individuals, the interaction between lipid droplets and mitochondria are impaired, likely leading 
to ineffective lipid transfer and altered metabolism [42]. Both instances would result in increased 
cellular lipids and possibly lipotoxic effects. In situations of excessive lipids, cells have been 
shown to efflux these bioactive molecules [34]. This increased circulation of lipids would then 
contribute to the aberrant lipid accumulation within uncommon cell types such as macrophages 
and hepatocytes, which are associated with disease states (i.e. atherosclerosis and hepatic 
steatosis) [43], [44]. While studies on obesity have been focused on inflammation, endocrine 
signaling, and organismal lipid accumulation, further understanding of how lipid droplets 
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properly store and regulate lipids may provide important insights on the roles that they play in 
metabolic disorders. 
1.4 Non-canonical roles of lipid droplets 
Lipid droplets have a highly dynamic range of size, unique structure, and intrinsic supply of 
lipid substrates. Cells have taken advantage of these characteristics and utilized lipid droplets for 
cellular functions beyond lipid storage. While all non-canonical functions are not known, their 
potential roles are hinted at by the diversity of lipid droplet associated proteins revealed in 
proteomic studies [45], [46].  
The lipid droplet’s cytoplasmic surface provides a unique surface for unconventional protein 
interactions. Drosophila embryos have taken advantage of this surface by utilizing it as a 
dynamic protein depot. Maternally deposited histones are stored on the lipid droplet surface 
through association with the lipid droplet protein Jabba. This association limits the degradation 
and toxic effects of free histones while allowing for their trafficking to nuclei as they are needed 
for embryo development. The surplus of histones also serves the secondary purpose of protecting 
the embryo from intracellular bacterial infections [46]. Yeast on the other hand, have been 
observed to utilize the lipid droplet surface as a protein carrier. The hydrophobic core and 
hydrophilic exterior allow effective association with unfolded ER proteins and their trafficking 
across the cytosol for degradation in the vacuole [47]. 
As the main lipid storage organelle, lipid droplets are poised to react to metabolic cues and 
alter their size and composition. Through changes in surface properties, lipid droplets are able to 
recruit or evict proteins, enabling cells to utilize these metabolic responses as a means of protein 
regulation. Bacterial lipid droplets have been observed to interact with genomic DNA under 
conditions of nutritional or UV stress. This association in turn, alters transcription and stabilizes 
DNA to promote survival [48]. Within adipocytes, the lipid droplet protein, Fsp27, associates 
with the transcription factor, Nfat5, sequestering it from the nucleus [49]. Changes in lipid 
metabolism leading to the dissociation of Fsp27 would then allow Nfat5 to enter the nucleus and 
induce its target gene expression. 
The lipid droplet’s ability to quickly store or mobilize resources enable the cell to 
effectively respond in situations of cellular stress. Upon nutrient deprivation for example, lipid 
droplets mobilize lipids to provide energy, but are also capable of limiting their utilization under 
extended periods of starvation to promote long term survival [50], [51]. This active control over 
lipid stores can also serve a protective role in situations of oxidative stress. By upregulating 
deposition of essential sensitive lipids such as polyunsaturated fatty acids, glial cells of 
developing Drosophila can limit oxidation of these molecules and preserve membrane quality 
and cellular function of neural stem cells [52]. However, it has been observed that accumulation 
of peroxidized lipids within glia, as a result of neuronal mitochondrial dysfunction, can precede 
neurodegeneration [53]. Whether the differences in developmental stage or mitochondrial 
function are the cause of these two contrasting outcomes is unknown, however, the formation of 
lipid droplets remains a clear response to oxidative stress. 
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Lipid droplets are also able to utilize their lipid stores in non-canonical ways. Clearance 
of specific inclusion bodies has been shown to be dependent on mobilization of lipid droplet 
sterol-metabolites. These sterols are likely used for production of chemical chaperones such as 
bile acids, sterol-based amphipathic molecules utilized for solubilization of nutrients during 
digestion [54]. It is evident that lipid droplets play many critical roles beyond lipid storage, and 





Chapter 2: Materials and methods 
Nematode Strains 
N2 Bristol, CF512 (rrf-3(b2); fem-1(hc17)), LIU1 (ldrIs[dhs-3p::dhs-3::GFP]), SJ4005 
(zcIs4[hsp-4p::GFP]), SJ4100 (zcIs13[hsp-6p::GFP]), CL2070 (dvIs70[hsp-16.2p::GFP]), VS25 
(hjIs[vha-6p::GFP::C34B2.10(SP12) + unc-119(+)]),EG6703 (unc-119(ed3); cxTi10816; 
oxEx1582[eft-3p::GFP + Cbr-unc-119]) strains were obtained from the Caenorhabditis Genetics 
Center (CGC). AGD1403 (uthIs387[gly-19p::xbp-1s, myo-2p::tdTomato]; zcIs4[hsp-4p::GFP]) 
was previously created in this lab [13]. Transgenic strains created for this study were generated 
from EG6703 via the MosSCI method [55] or through crossing strains. 
Transgenic strains created: 
AGD2192 (unc-119(ed3) III; uthSi60[vha-6p::ER-signal-sequence::mRuby::HDEL::unc-54 
UTR, cb-unc-119(+)] I) 
AGD2319 (unc-119(ed3) III; uthSi62[vha-6p::MLS::mRuby::unc-54 UTR, cb-unc-119(+)] I) 
AGD2424 (unc-119(ed3) III; uthSi65[vha-6p::ERss::mRuby::ire-1a (344-967aa)::unc-54 3'UTR 
cb-unc-119(+)] IV) 
AGD2425 (unc-119(ed3) III; uthSi65[vha-6p::ERss::mRuby::ire-1a (344-967aa)::unc-54 3'UTR 
cb-unc-119(+)] IV; zcls4[hsp-4p::GFP]V) 
Worm growth and maintenance 
All worms were maintained at 20°C on NGM agar plates seeded with OP50 E. coli bacteria. 
Prior to experiments, worms were bleach synchronized as described in [56], followed by 
overnight L1 arrest in M9 buffer (22 mM KH2PO4 monobasic, 42.3 mM Na2HPO4, 85.6 mM 
NaCl, 1 mM MgSO4) at 20°C. For RNAi and lifespan experiments, arrested L1s were plated on 
1µm IPTG, 100 µg/mL Carbenicillin NGM agar plates seeded with RNAi bacteria and 
maintained at 20°C. 
Lifespan and tunicamycin survival assays 
Lifespan analyses were conducted on NGM agar plates with specified RNAi bacteria at 20°C. 
Animals were moved daily for 4-7 days to new RNAi plates until progeny were no longer 
observed. Worms with protruding intestines, bagging phenotypes, or other forms of injury were 
scored as censored and not counted as part of the analysis. For combined RNAi lifespans, 
saturated cultures were mix 1:1 by volume. Tunicamycin survival assays were conducted with 
the same protocols on RNAi plates containing 25ng/uL of tunicamycin in DMSO, or equal 
volume of DMSO only. 
Lipid droplet enrichment 
CF512 worms were L1 synchronized and plated on NGM RNAi plates with Empty Vector 
bacteria and maintained at 25°C until day 1, after which they were moved to 20°C. ~200,000 
worms were collected with M9 buffer and washed with M9 buffer + 0.1% Tween 20, followed 
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by 3x washes with M9 buffer. Worms were then treated with Collagenase type 3 (Worthington 
Biochemical, CLS-3) at 1 mg/mL in Collagenase buffer for 30 minutes at 20°C, followed by 5x 
washes with M9. 
Lipid droplet enrichment protocols were adapted from [57]. Briefly, nematodes were washed 2x 
with ice-cold Buffer A and then homogenized 20x in 8 mL of Buffer A + Protease inhibitor (PI) 
(EMD Millipore, 20-201) using a 15 mL Dura-Grind Stainless Steel Dounce Tissue Grinder 
(VWR, 62400-686). Crude lysates were then transferred to 15 mL conical tubes on ice, topped to 
10.5 mL with Buffer A + PI, and spun @ 1,500xG for 11 minutes at 4°C to pellet carcasses and 
debris. 9 mL of cleared lysates were transferred to SW41 tubes on ice and carefully layered with 
3 mL of ice-cold Buffer B + PI. Samples were spun @15,000xG for 70 minutes at 4°C in an 
SW41 rotor without engaging breaks. The top ~1.25 mL lipid droplet “worm cream” fractions 
were collected into 1.5 mL tubes and frozen in liquid N2. 
Proteomic analysis of enriched lipid droplets 
Proteins from frozen lipid droplet fractions were precipitated through methanol/chloroform 
extraction. Briefly, samples were mixed with ice-cold methanol and chloroform at 1:1:1 ratios 
and mixed @ 1400 RPM for 20 minutes at 4°C. Mixed samples were then spun @ 20,000xG for 
10 minutes at 4°C. Upper and lower phases were collected before the precipitated proteins were 
washed 2x with ice-cold methanol. Proteins were briefly allowed to dry and then resuspended in 
8 M urea Laemmli buffer without bromophenol blue. Protein concentrations were then quantified 
with a Pierce BCA Protein Assay Kit. 15-20 µg of protein were run 5-10 mm into the resolving 
gel of a protein gel (NuPAGE Novex, NP0336BOX) and stained with stained with Colloidal 
Blue (Invitrogen, LC6025). Stained protein bands were cut out and submitted to the UC Davis 
Proteomics Core for in-gel digest and LC-MS/MS.  
RAW files were then analyzed with MaxQuant proteomics software to identify peptides based on 
the UniProt database C. elegans proteome. Briefly, trypsin was selected as the digestion enzyme, 
requantify (match from and to) was selected, match between run was selected, and iBAQ was 
selected. The remaining options were left at default settings. Contaminants, reverse, and only 
identified by site proteins were then removed from the list of identified proteins. The remaining 
proteins were then assessed for iBAQ values in all three replicates or removed. In cases of 
peptides matching multiple proteins, both proteins were included. 
Lysate supplementation 
Crude lysate was obtained from N2 worms grown on 40x concentrated EV bacteria at 20°C. 
~120,000 day 1 adult worms were collected with M9 and treated with Collagenase type 3 
(Worthington Biochemical, CLS-3) at 1 mg/mL in Collagenase buffer for 1 hour at 20°C. 
Animals were then washed 6x with M9 buffer and homogenized 20x in 3 mL of M9 buffer using 
a 15 mL Dura-Grind Stainless Steel Dounce Tissue Grinder (VWR, 62400-686). Crude lysate 
was transferred to 1.5 mL tubes and frozen in liquid N2. 
Supplementation experiments were prepared by mixing 4x concentrated RNAi bacteria with 
crude lysate at a 2:1 ratio, respectively. The lysate mixture was plated on RNAi plates and 
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allowed to dry. Dried plates were then UV irradiated without lids for 9 minutes in an ultraviolet 
crosslinker (UVP, CL-1000) before plating L1 arrested worms on the plate. 
Fluorescent microscopy 
Transcriptional reporter strains were imaged using a Leica DFC3000 G camera mounted on a 
Leica M205 FA microscope. Worms were grown to day 1 of adulthood at 20°C, hand-picked, 
and immobilized with 100 mM Sodium Azide M9 buffer on NGM agar plates. Raw images were 
cropped, and contrast matched using ImageJ software. 
High-magnification fluorescent images were acquired with a Leica DFC9000 GT camera 
mounted on a Leica DM6000 B microscope. Day 1 worms were picked onto 10 mM Sodium 
Azide M9 buffer on slides and imaged within 15 minutes. Raw images were cropped and 
independently contrast optimized for clarity using ImageJ software. 
Confocal images were acquired using a 3i Marianas spinning-disc confocal platform. Day 1 
worms were picked onto 10 mM Sodium Azide M9 buffer on slides and imaged within 15 
minutes. Raw images were cropped and independently contrast optimized for clarity using 
ImageJ software. 
For the initial screen of hsp-4p::GFP animals, fluorescence was scored on the following criteria: 
2 = increased fluorescence, 1 = possible increase in fluorescence, 0 = no change, -0.5 = small 
regions of dimmer fluorescence, -1= small regions of complete loss of fluorescence, -1.5 = 
globally dimmer fluorescence and some regions of no fluorescence, -2 = global loss of 
fluorescence and small regions of dim fluorescence, -2.5 = global loss of fluorescence except for 
regions within spermatheca, -3 = complete loss of fluorescence.  
FRAP analysis 
FRAP 4D images were acquired using a 3i Marianas spinning-disc confocal platform. 
Photobleaching of a 10 µm x 10 µm region within a 4 µm Z-stack was performed using a 488 nm 
laser for 1-2 ms. Raw images were processed with ImageJ into sum Z-projections and aligned 
using the “RigidBody” setting of the StackReg ImageJ plugin. FRAP analysis was performed 
with the FRAP Profiler ImageJ plugin by selecting the 10 µm x 10 µm photobleached region as 





Chapter 3: let-767, a sterol hydrogenase, is critical for ER homeostasis 
3.1 Results 
A LD protein screen for modulators of the ER stress response. 
The ER is a major site for both protein and lipid synthesis. Under proteotoxic stress, the 
ER launches genetic programs that not only result in increased chaperone expression, but also 
modify the ER’s lipid bilayer, the site of LD biogenesis [58]. LDs function as hubs for 
maintaining lipid homeostasis by regulating storage and release of structural, signaling, and 
energy storage lipids [46]. Interestingly, they have also been shown to contribute to protein 
quality control [47], [54]. Here, we sought to study the functional relationship between LD 
quality and the ER stress response. In order to identity LD interactors, we performed a proteomic 
analysis of an LD enriched fraction from day 1 adult nematodes. We identified 540 LD fraction 
proteins, including proteins previously verified to localize to lipid droplets: DHS-3, PLIN-1, 
LDP-1 and ACS-4 [59]–[61]. To increase our confidence in proteins that likely interact with 
LDs, we performed a meta-analysis of our findings against C. elegans LD proteomes previously 
published from two independent labs [59]–[61]. We identified 120 proteins common to these 
three independent studies conducted with different experimental techniques (Fig.1B). 
To determine the impact of these LD proteins on the ER stress response, we carried out 
an RNAi screen to identity genes which altered induction of the UPRER under conditions of 
proteotoxic stress. We utilized a transcriptional reporter composed of the hsp-4 (C. elegans 
Hsp70/BiP chaperone protein) promoter driving GFP expression (hsp-4p::GFP) to assess the 
UPRER induction and sec-11 (an ER serine-peptidase) RNAi to generate ER stress and robustly 
induce the GFP reporter (Fig.1C). In combination with the sec-11 RNAi, we individually 
knocked down our 120 candidate LD genes to perform a double RNAi screen. Of the available 
RNAis for the 120 candidates, we found that interference of 49 genes led to reduced induction of 
the UPRER reporter (Table 1). While a large portion of these genes are annotated as functioning 
in general transcription or translation (e.g. ribosomal subunits), a subset of 11 were potential 
novel modulators of the UPRER (Fig.1C). 
LET-767, a hydroxysteroid dehydrogenase, is critical for ER homeostasis. 
Our initial literature search of the 11 genes highlighted let-767 as the only gene 
previously characterized to directly affect lipid metabolism. LET-767 is a hydroxysteroid 
dehydrogenase implicated in monomethyl branched-chain fatty acids (mmBCFA) synthesis and 
steroid metabolism, as well as being necessary for normal growth and reproductive development 
[62]–[64]. Since let-767 has been shown to be primarily expressed in the intestine and localize to 
the ER [62], we determined the impact of  let-767 RNAi on intestinal LDs and ER. We found 
that knockdown of let-767 caused a significant reduction in LD size and number, as well as 
significant disruption of the ER morphology. To determine whether these perturbations were 
restricted to LDs and the ER or a more global phenotype, we also examined the effect of let-767 
RNAi on mitochondrial morphology. The RNAi treatment resulted in a severely fragmented 
network and enlarged mitochondria (Fig2.A). 
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Due to the severe defects in organelle morphology, we tested whether let-767 RNAi 
alone would induce the UPRER or the UPRmito.  Surprisingly, these animals only displayed a mild 
induction of the UPRER and no activation of the UPRmito. However, under conditions of stress, 
only the UPRER induction was compromised (Fig.2B-C). To further test whether the stress 
response suppression was specific to the ER or due to general defects in these animals, we tested 
the heat shock response (HSR). let-767 RNAi had no effect on basal or heat-stress induced 
activation of the HSR (Fig.2D), indicating that let-767 plays a specific role in maintaining ER 
homeostasis.  
let-767 mediated UPRER suppression is not due to loss of mmBCFAs 
In agreement with previous studies, we observed a gross reduction in animal size and 
reproductive capacity with let-767 RNAi treatment (Fig.3A). Previous work has implicated let-
767 as the 3-keto acyl reductase in mmBCFA synthesis required for normal F1development, 
primarily C17 mmBCFA (isoC17) synthesis [62], [65]. While phenotypes associated with loss of 
let-767 have been shown to be amplified by cholesterol depletion [64], these enhancements were 
likely due to the role of isoC17 in cholesterol mobilization [66]. To determine whether the 
defects we observed in let-767 knockdown animals were a result of insufficient mmBCFAs, we 
supplemented animals grown on let-767 RNAi with exogenous isoC17. Supplementation of the 
C17 mmBCFA did not rescue let-767 RNAi treated animal growth or reproductive development. 
However, isoC17 supplementation was able to rescue the F1 larval arrest of RNAi targeting elo-
5, the elongase mainly responsible for isoC17 production [67], suggesting that isoC17 mmBCFA 
was properly delivered to the animals (Fig.3A). Similarly, isoC17 supplementation was not able 
to rescue the suppressed UPRER signaling or disrupted ER morphology caused by let-767 
knockdown (Fig.3B-C), suggesting that the ER phenotypes are not simply due to insufficient 
mmBCFA synthesis. 
Due to the ineffective rescue of mmBCFA supplementation and the general depletion 
lipid droplets, we questioned whether a complete panel of lipids would be able to rescue the 
phenotypes. To this end, we supplemented animals grown on let-767 RNAi with crude lysate 
isolated from wild type (N2) animals, which would likely contain all the essential lipids for C. 
elegans survival and development. Indeed, supplementing crude lysate improved the ER 
morphology to near wild-type conditions, as well as the abundance and size of lipid droplets 
(Fig.3D). Surprisingly, the restored ER morphology and improved growth did not reestablish 
normal UPRER signaling in response to ER stress (Fig.3E), implying distinct functional 
mechanisms for let-767 dependent changes on ER morphology and UPRER activation. 
Knockdown of the let-767 metabolic pathway restores signaling of the UPRER 
Since the supplementation of all essential lipids was not sufficient to recover the UPRER 
signaling to WT levels, we considered the possibility that UPRER signaling could be 
compromised in let-767 knockdown animals due to the accumulation of a toxic metabolic 
intermediate. To test this hypothesis, we coupled let-767 RNAi with knockdown of sbp-1, the 
ortholog of human SREBP, a major transcriptional regulator of key enzymes within the isoC17 
metabolic pathway [68]. Indeed, analysis of a previously published RNAseq dataset of sbp-1 
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RNAi treated nematodes confirmed downregulation of mmBCFA associated genes including let-
767 and elo-5 [69]. From our double RNAi of sbp-1 and tandem let-767/sec-11, we observed a 
significant recovery of stress-induced UPRER signaling in let-767 knockdown animals (Fig.4A) 
and a marked improvement in animal size and reproductive development. Moreover, sbp-1 RNAi 
greatly improved the lifespan defects of let-767 knockdown animals (Fig.4B). Similarly, sbp-1 
knockdown rescued the survival of let-767 RNAi treated animals under the proteotoxic ER stress 
of Tunicamycin, an N-linked glycosylation inhibitor (Fig.4C-D). Lastly, we determined whether 
sbp-1 RNAi could also suppress the defects in ER morphology caused by let-767 knockdown. As 
expected, we observed a depletion of lipid droplets and a slight perturbation of the ER 
morphology with sbp-1 RNAi (Fig.4D). More importantly, under let-767 RNAi conditions, sbp-
1 RNAi had only mild effects on ER and lipid droplet morphology, suggesting that limiting the 
let-767 metabolic pathway through sbp-1 knockdown is not enough to restore ER and LD 
morphology. However, in the presence of crude lysate, both sbp-1 RNAi alone or combined with 
let-767 RNAi resulted in ER and lipid droplet morphology resembling WT animals (Fig.4D). 
These results are congruent with SREBP’s central role in maintaining lipid homeostasis [24]. 
While reducing the let-767 metabolic pathway restores UPRER signaling, loss of additional lipid 
pathways requires that those lipids be supplemented to maintain lipid homeostasis. Moreover, 
these data indicate that LET-767 function impacts two aspects of ER quality: lipid synthesis 
required for proper organelle morphology and turnover of a toxic metabolite which negatively 
impacts the ER stress response. 
Compromised UPRER through reduced membrane quality in let-767 knockdown animals. 
Finally, we sought to determine how potential accumulation of a metabolite in let-767 
knockdown animals could impact the UPRER. The isoC17 pathway has been previously 
hypothesized to produce a toxic metabolite that can alter membrane quality and signaling [70]. 
Therefore, we considered the possibility that accumulation of a metabolite from the let-767 
pathway could be altering the ER membrane and preventing UPRER signaling, resulting in 
decreased organelle function and overall health. To determine if the membrane quality was 
perturbed, we probed ER membrane dynamics by performing Fluorescence Recovery After 
Photobleaching (FRAP) utilizing luminal and transmembrane ER fluorescent markers [71]. From 
our analysis, we observed that let-767 knockdown resulted in a highly reduced mobile fractions 
of both luminal and membrane markers, consistent with animals exhibiting general defects in ER 
morphology and membrane dynamics. Upon lysate supplementation, the luminal mobile fraction 
of let-767 knockdown animals had a significant recovery to 80% of WT level, while the 
membrane marker mobile fraction only recovered to 54% of WT suggested that the membrane 
mobility is much more disrupted by let-767 RNAi (Fig.5A-B). 
Proper UPRER signaling is dependent on dimerization of IRE-1 to splice xbp-1 mRNA to 
its active xbp-1s form [5]. Therefore, one possibility is that decreased membrane mobility 
impedes IRE-1 activity, leading to a compromised ER stress response. To test this hypothesis, 
we examined the impact of let-767 knockdown on ectopic UPRER activation at two different 
points along the same mechanistic pathway: 1) overexpression of ire-1, which would require 
proper IRE-1 dimerization, and 2) overexpression of the active xbp-1s isoform, which would 
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bypass the requirement of IRE-1 dimerization. While over-expression of full-length ire-1 (ire-1a 
OE) proved to be lethal, over-expression of ire-1 lacking a significant portion of the luminal 
domain (ire-1b OE) was viable. By creating an RNAi targeting the luminal domain, we 
confirmed that intestinal ire-1b OE was sufficient to induce intestinal UPRER signaling without 
the endogenous ire-1a (Fig.5C-D). As expected, let-767 knockdown resulted in a considerable 
reduction of ire-1b OE mediated UPRER induction. More importantly, let-767 knockdown only 
mildly reduced xbp-1s OE induction of the UPRER, suggesting that xbp-1s can at least partly 
bypass the detrimental effects of let-767 RNAi on the ER stress response (Fig.5E-F). These data 
strongly support our hypothesis that let-767 knockdown compromises induction of the UPRER by 





Cells must be able to monitor and maintain both lipid and protein homeostasis to preserve 
cellular function. The ER is uniquely a major site of lipid synthesis and protein trafficking, 
supplying lipids to multiple organelles and processing a third of the cell’s proteins. The ER is 
also responsible for the biogenesis of lipid droplets, the cell’s lipid storage organelle. Along with 
their lipid regulating functions, lipid droplets have also been shown to contribute to protein 
quality control. Here, we aimed to assess the functional relationship between lipid droplets and 
the ER’s protein quality control system, the UPRER. In doing so, we identified the ER protein, 
LET-767, as a novel regulator of ER homeostasis. 
 Through our screen of lipid droplet associated proteins, we found that LET-767 function 
was necessary for proper induction of the UPRER. Interestingly, LET-767 localizes to the ER and 
not lipid droplets, as detected by fluorescence microscopy [62]. Consistent with this localization, 
LET-767 is predicted to contain an ER signal sequence and at least one transmembrane domain 
(http://topcons.cbr.su.se/). Our list of candidate lipid droplet proteins containing LET-767 was 
derived from LD proteomes isolated by two independent labs [59]–[61]. While this comparison 
improves our confidence in potential lipid droplet interacting proteins, it does not verify their 
interaction. Lipid droplets are generally isolated through their buoyancy due to their high lipid 
content [57]. As a result of their direct interaction with multiple organelles, LD isolations naturally 
contain associated membranes and their proteins [72]. Nonetheless, it is worth noting that the 
closest mammalian orthologs of let-767 (HSD17B3, HSD17B12, and HSDL1) have also been 
identified in mammalian LD isolations [73], [74]. While not likely to be directly localized to lipids 
droplets, our evidence shows that LET-767 function has a definite impact on lipid droplet and ER 
morphology, though whether LET-767 plays direct role in lipid droplet biogenesis on the ER 
membrane remains to be established. 
 let-767 has been previously characterized as a 3-ketoacyl-CoA reductase involved in 
isoC17 fatty acid elongation and as a 17β-hydroxysteroid dehydrogenase capable of 
metabolizing steroid hormones in mammalian cells [62], [63]. mmBCFAs have been shown to be 
required for development in C. elegans, likely through synthesis of d17iso-glucosylceramide, a 
glycosphingolipid involved in cholesterol mobilization and TORC1 signaling [66], [75]. In this 
study, isoC17 supplementation did not rescue growth, organelle morphology, or UPRER 
phenotypes. Yet, consistent with a reduction in isoC17 synthesis, we did observe an increased 
requirement for cholesterol in let-767 knockdown animals grown in dense conditions (data now 
shown). Growth and morphology phenotypes of let-767 knockdown were however, rescued by 
complete lipid supplementation by means of crude lysate. Multiple steroid hormones have been 
identified in C. elegans and could be potential metabolites of LET-767, which eventually alter 
lipid pathways through binding of nuclear hormone receptors [76]. Supplementation of these 
potential ligands through crude lysate would then be expected to rescue let-767 knockdown 
phenotypes, although, to date, let-767 has not been implicated in any specific sterol pathway in 
C. elegans. Interestingly, the complete lipid supplementation was unable to restore UPRER 
signaling and indicated to us that in addition to the loss of LET-767 products, accumulation of its 
substrates could also be contributing to the let-767 knockdown phenotypes. This evidence and 
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the compromised ER, mitochondrial, and lipid droplet organelles of let-767 knockdown suggest 
a more complex role for LET-767 in lipid metabolism than is currently known. 
Sensors within the ER membrane are capable of detecting membrane lipid disequilibrium 
and activating the UPRER [26], [27]. Here we find a contrasting response: knockdown of the lipid 
enzyme, let-767, results in suppression of the UPRER. We hypothesized that accumulation of a 
toxic LET-767 substrate could be disrupting the ER membrane and compromising membrane 
function. As dimerization of IRE-1 is required for its signaling function [5], reduced membrane 
mobility could certainly impact IRE-1 interactions, thereby suppressing the UPRER by preventing 
IRE-1 mediated splicing of xbp-1 to xbp-1s. Indeed, by knocking down sbp-1, a transcription 
factor upstream of the let-767 lipid pathway [68], [69], we observed a significant rescue of the 
UPRER, as well as improved lifespan and ER stress survival. Thus, it is likely that LET-767 
processes a lipid metabolite downstream of sbp-1 that is essential to maintaining membrane 
dynamics and ultimately, induction of the UPRER.  
Interestingly, while sbp-1 knockdown ameliorated the defects in UPRER induction, 
growth, and organismal health in let-767 knockdown animals, there was no effect on organelle 
morphology. Although knockdown of sbp-1 potentially prevents the accumulation of the LET-
767 substrate to alleviate detrimental phenotypes, as a transcription factor for major lipogenic 
pathways [24], sbp-1 knockdown likely failed to fully rescue organelle morphology of let-767 
deficient animals due to insufficient lipid production. Thus, let-767 knockdown animals require 
lipid supplementation for full restoration of organelle morphology, hinting that some of the 
phenotypes are a result of insufficient lipid production. While this reduction in lipids may be due 
to changes in nuclear hormone ligand production, as previously mentioned, a compromised ER 
membrane could instead be the cause due to the major role the ER membrane plays in lipid 
production. 
Through FRAP microscopy we then determined whether ER dynamics were in fact 
disrupted by let-767 knockdown. We found that both membrane and luminal mobility was 
significantly impacted by let-767 RNAi. While changes in global lipid metabolism and ER 
structure are a potential cause of altered luminal dynamics, we observed that by restoring ER 
morphology through supplementation of essential lipids via crude lysate, only the membrane 
mobile fraction remained substantially reduced. These data provide additional evidence that a 
potential LET-767 toxic substrate is altering ER membrane quality independent of its effects on 
lipid production. 
 UPRER induction through ectopic expression of xbp-1s would be independent of ER 
membrane functionality, as this would bypass the need of IRE-1 oligomerization and subsequent 
splicing of xbp-1 mRNA. We find that in let-767 knockdown animals, induction of UPRER via 
ire-1b overexpression was significantly reduced, while UPRER induction via xbp-1s 
overexpression was only mildly affected. Although the generally reduced health of let-767 
knockdown animals may impact UPRER induction, our evidence supports a model where LET-
767 impacts UPRER induction via ER membrane homeostasis and IRE-1 function.  
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 In our current model, let-767 is required to maintain ER homeostasis. While we are 
currently investigating which specific lipids are regulated by LET-767, its function clearly 
affects both lipid and protein homeostasis. Loss of let-767 results in accumulation of substrate 
metabolites, which disrupt transmembrane protein function, thereby reducing UPRER signaling 
and lipid synthesis. While exogenous lipids can compensate for deficient lipid synthesis, 
restoration of UPRER signaling requires knockdown of the let-767 pathway to eliminate 






Table 1. Candidate LD proteins identified by proteomics meta-analysis 
 




inf-1 F57B9.6 Eukaryotic initiation factor 4A   -3 L4/Adult 
rpl-10 F10B5.1 60S ribosomal protein L10   -3 L4/Adult 
rpl-13 C32E8.2 60S ribosomal protein L13   -3 L3/L4 
rpl-16 M01F1.2 60S ribosomal protein L13a   -3 L2/L3 
rpl-17 Y48G8AL.8 60S ribosomal protein L17   -3 L4/Adult 
rpl-19 C09D4.5 60S ribosomal protein L19   -3 L3 
rpl-20 E04A4.8 60S ribosomal protein L18a   -3 Adult 
rpl-23 B0336.10 60S ribosomal protein L23   -3 Adult 
rpl-3 F13B10.2 60S ribosomal protein L3   -3 L3 
rpl-35 ZK652.4 60S ribosomal protein L35   -3 L3/L4 
rpl-9 R13A5.8 60S ribosomal protein L9   -3 L4/Adult 
rps-0 B0393.1 40S ribosomal protein SA   -3 Adult 
rps-1 F56F3.5 40S ribosomal protein S3a   -3 L3 
rps-10 D1007.6 Ribosomal Protein, Small subunit   -3 Adult 
rps-16 T01C3.6 40S ribosomal protein S16   -3 Adult 
rps-18 Y57G11C.16 Ribosomal Protein, Small subunit   -3 L3/L4 
rps-19 T05F1.3 40S ribosomal protein S19   -3 Adult 
rps-20 Y105E8A.16 Ribosomal Protein, Small subunit   -3 L4/Adult 
rps-3 C23G10.3 40S ribosomal protein S3   -3 L3/L4 
rps-5 T05E11.1 40S ribosomal protein S5   -3 Adult 
rps-8 F42C5.8 40S ribosomal protein S8   -3 L4/Adult 
rps-9 F40F8.10 40S ribosomal protein S9   -3 L3/L4 
atp-1 H28O16.1 ATP synthase subunit alpha, mitochondrial   -2.5 L3/L4 
eef-1A.1 F31E3.5 Elongation factor 1-alpha   -2.5 Adult 
eef-2 F25H5.4 Elongation factor 2   -2.5 Adult 
rla-0 F25H2.10 60S acidic ribosomal protein P0   -2.5 Adult 
rpl-2 B0250.1 60S ribosomal protein L8   -2.5 L4/Adult 
rpl-22 C27A2.2 60S ribosomal protein L22   -2.5 L4/Adult 
rpl-27 C53H9.1 60S ribosomal protein L27   -2.5 Adult 
rpl-36 F37C12.4 60S ribosomal protein L36   -2.5 L4/Adult 
rpl-6 R151.3 60S ribosomal protein L6   -2.5 Adult 
rps-14 F37C12.9 40S ribosomal protein S14   -2.5 Adult 
rps-15 F36A2.6 40S ribosomal protein S15   -2.5 Adult 
rps-22 F53A3.3 Ribosomal Protein, Small subunit   -2.5 L4/Adult 
rps-7 ZC434.2 40S ribosomal protein S7   -2.5 Adult 
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atp-2 C34E10.6 ATP synthase subunit beta, mitochondrial   -2 L3/L4 
fib-1 T01C3.7 rRNA 2'-O-methyltransferase fibrillarin   -2 Adult 
rab-1 C39F7.4 RAB family   -2 L3/L4 
rpl-18 Y45F10D.12 60S ribosomal protein L18   -2 Adult 
rpl-5 F54C9.5 60S ribosomal protein L5   -2 Adult 
rps-11 F40F11.1 Ribosomal Protein, Small subunit   -2 Adult 
rps-2 C49H3.11 40S ribosomal protein S2   -2 Adult 
hsp-1 F26D10.3 Heat shock 70 kDa protein A   -1.5 Adult 
hsp-90 C47E8.5 Heat shock protein 90   -1.5 Adult 
let-767 C56G2.6 Very-long-chain 3-oxooacyl-coA reductase let-767   -1.5 Adult 
tba-2 C47B2.3 Tubulin alpha-2 chain   -1.5 Adult 
ucr-1 F56D2.1 Cytochrome b-c1 complex subunit 1, mitochondrial   -1.5 Adult 
vha-13 Y49A3A.2 V-type proton ATPase catalytic subunit A   -1.5 L3/L4 
vha-15 T14F9.1 Probable V-type proton ATPase subunit H 2   -1.5 L3/L4 
act-4 M03F4.2 Actin-4   -1 Adult 
ant-1.1 T27E9.1 Adenine Nucleotide Translocator   -1 Adult 
atad-3 F54B3.3 ATPase family AAA domain-containing protein 3   -1 Adult 
eat-6 B0365.3 Sodium/potassium-transporting ATPase subunit alpha   -1 Adult 
eef-1G F17C11.9 Probable elongation factor 1-gamma   -1 L4/Adult 
F42G8.10 F42G8.10 NADH:ubiquinone oxidoreductase subunit B11 -1 Adult 
hsp-60 Y22D7AL.5 Chaperonin homolog Hsp-60, mitochondrial   -1 Adult 
T02H6.11 T02H6.11 ubiquinol-cytochrome c reductase binding protein -1 Adult 
tba-4 F44F4.11 Tubulin alpha chain   -1 Adult 
Y7A5A.1 Y7A5A.1 24-dehydrocholesterol reductase -1 Adult 
acs-17 C46F4.2 Fatty Acid CoA Synthetase family   -0.5 Adult 
ant-1.3 K01H12.2 Adenine Nucleotide Translocator; Mitochondrial -0.5 Adult 
B0491.5 B0491.5 enriched in the OLL, the PVD, and the germ line -0.5 Adult 
gdh-1 ZK829.4 Glutamate dehydrogenase   -0.5 Adult 
ldp-1 F22F7.1 Lipid droplet localized protein   -0.5 Adult 
nuo-2 T10E9.7 NADH Ubiquinone Oxidoreductase   -0.5 Adult 
rab-7 W03C9.3 RAB family   -0.5 Adult 
rack-1 K04D7.1 Guanine nucleotide-binding protein subunit beta-2-like 1   -0.5 Adult 
rpl-31 W09C5.6 60S ribosomal protein L31   -0.5 Adult 
rps-4 Y43B11AR.4 40S ribosomal protein S4   -0.5 Adult 
algn-2 F09E5.2 Asparagine Linked Glycosylation (ALG) homolog, Nematode   0 Adult 
alh-8 F13D12.4 Probable methylmalonate-semialdehyde dehydrogenase  0 Adult 
cgh-1 C07H6.5 ATP-dependent RNA helicase cgh-1   0 Adult 
cts-1 T20G5.2 Probable citrate synthase, mitochondrial   0 Adult 
D2030.4 D2030.4 NADH dehydrogenase  0 Adult 
dhs-19 T11F9.11 DeHydrogenases, Short chain   0 Adult 
dhs-3 T02E1.5 DeHydrogenases, Short chain 0 Adult 
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F01G4.6 F01G4.6 Phosphate carrier protein, mitochondrial   0 Adult 
F44B9.5 F44B9.5 Ancient ubiquitous protein 1 homolog   0 Adult 
F52H2.6 F52H2.6 Diminuto-like protein   0 Adult 
lec-1 W09H1.6 32 kDa beta-galactoside-binding lectin   0 Adult 
par-5 M117.2 14-3-3-like protein 1   0 Adult 
pdi-2 C07A12.4 Protein disulfide-isomerase 2   0 Adult 
phb-2 T24H7.1 Mitochondrial prohibitin complex protein 2   0 Adult 
plin-1 W01A8.1 Perilipin-1 homolog   0 Adult 
rpl-32 T24B8.1 Ribosomal Protein, Large subunit   0 Adult 
tba-7 T28D6.2 Tubulin alpha chain   0 Adult 
tomm-20 F23H12.2 Mitochondrial import receptor subunit TOM20 homolog   0 Adult 
unc-108 F53F10.4 RAB2A, member RAS oncogene family 0 Adult 
vdac-1 R05G6.7 Probable voltage-dependent anion-selective channel   0 Adult 
vit-1 K09F5.2 Vitellogenin-1   0 Adult 
vit-2 C42D8.2 Vitellogenin-2   0 Adult 
vit-6 K07H8.6 Vitellogenin-6   0 Adult 
acs-4 F37C12.7 Fatty Acid CoA Synthetase family   0.5 Adult 
tbb-1 K01G5.7 Tubulin beta chain   0.5 Adult 
alh-4 T05H4.13 Aldehyde dehydrogenase   1 Adult 
enpl-1 T05E11.3 Endoplasmin homolog   1 Adult 
hsp-3 C15H9.6 Heat shock 70 kDa protein C   1 Adult 
vit-5 C04F6.1 Vitellogenin-5   1 Adult 
hsp-4 F43E2.8 Endoplasmic reticulum chaperone BiP homolog   2 Adult 
ben-1 C54C6.2 Tubulin beta chain   N/A N/A 
dhs-9 Y32H12A.3 DeHydrogenases, Short chain   N/A N/A 
eef-1A.2 R03G5.1 Elongation factor 1-alpha   N/A N/A 
faah-4 Y56A3A.12 Fatty Acid Amide Hydrolase homolog   N/A N/A 
rpl-1 Y71F9AL.13 60S ribosomal protein L10a   N/A N/A 
rpl-15 K11H12.2 60S ribosomal protein L15   N/A N/A 
rpl-21 C14B9.7 60S ribosomal protein L21   N/A N/A 
rpl-4 B0041.4 60S ribosomal protein L4   N/A N/A 
rpl-7 F53G12.10 60S ribosomal protein L7   N/A N/A 
rpl-7A Y24D9A.4 60S ribosomal protein L7a   N/A N/A 
rps-13 C16A3.9 40S ribosomal protein S13   N/A N/A 
rps-28 Y41D4B.5 40S ribosomal protein S28   N/A N/A 
rps-6 Y71A12B.1 40S ribosomal protein S6   N/A N/A 
sip-1 F43D9.4 Stress-induced protein 1   N/A N/A 
trap-1 Y71F9AM.6 TRanslocon-Associated Protein   N/A N/A 
tsn-1 F10G7.2 Staphylococcal nuclease domain-containing protein   N/A N/A 
vha-11 Y38F2AL.3 V-type proton ATPase subunit C   N/A N/A 
vit-4 F59D8.2 Vitellogenin-4   N/A N/A 
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Y53F4B.18 Y53F4B.18 fatty acid amide hydrolase 2 N/A N/A 
Y69A2AR.18 Y69A2AR.18 ATP synthase F1 subunit gamma N/A N/A 
ZK809.3 ZK809.3 X-ray repair cross complementing 5 N/A N/A 
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Figure 1. Identification of LD-associated proteins involved in ER quality control 
 
 
Figure 1. Identification of LD-associated proteins involved in ER quality control 
(A) Venn-diagram summarizing meta-analysis of this study’s LD isolation proteomics against 
previously published C. elegans LD isolation proteomes. (B) Schematic for screening method 
used to identify UPRER modulators from candidate LD-associated proteins. (C) Transgenic 
animals expressing hsp-4p::GFP grown on Empty Vector or sec-11 RNAi combined with either 
atp-1, atp-2, rab-1, fib-1, tba-2, let-767, hsp-90, hsp-1, ucr-1, vha-13, or vha-15 RNAi to assess 
effects on UPRER induction. All images contrast matched. 
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Figure 2. let-767 as a novel regulator of ER quality control 
(A) Transgenic animals expressing intestinal dhs-3::GFP, mCherry::HDEL, or mls::mRuby grown 
on Empty Vector or let-767 RNAi to characterize lipid droplet, ER, and mitochondrial 
morphology, respectively. Scale bar: 10 µm. (B) Transgenic animals expressing hsp-4p::GFP, 
grown on Empty Vector, let-767, and/or sec-11 RNAi to asses UPRER induction. Empty Vector 
used as control or sec-11 RNAi for induction of ER stress. (C) Transgenic animals expressing hsp-
6p::GFP, grown on Empty Vector, let-767, and/or cco-1 RNAi to asses UPRmito induction. Empty 
Vector used as control or cco-1 RNAi for induction of mitochondrial stress. (D) Transgenic 
animals expressing hsp-16.2p::GFP grown on Empty Vector or let-767 RNAi with or without 
heat-shock treatment to asses heat shock response. Animals imaged 2 hours after recovery at 20C°.  
Images for all transcriptional reporters contrast matched. Images in (A) contrast enhanced 








Figure 3. Whole animal lysate rescues defects in ER morphology but not UPRER induction 
(A) P0 N2 animals 3 days after synchronization or F1 progeny 6 days after initial synchronization 
on Empty Vector, let-767, or elo-5 RNAi bacteria grown in vehicle or isoC17 mmBCFA 
supplemented media to assess supplementation efficacy. Black arrows denote F1 animals arrested 
at L1 stage. White arrows denote P0 animals at day 6. (B) Transgenic animals expressing hsp-
4p::GFP grown on Empty Vector or let-767 RNAi combined with Empty Vector or sec-11 RNAi 
to asses UPRER induction. Bacteria grown in media supplemented with vehicle or isoC17 
mmBCFA. (C) Transgenic animals expressing an intestinal mRuby::HDEL ER marker grown on 
Empty Vector or let-767 RNAi bacteria grown in vehicle or isoC17 mmBCFA supplemented 
media to asses ER morphology. Scale bar: 5 µm. (D) Transgenic animals expressing intestinal 
mRuby::HDEL grown on Empty Vector or let-767 RNAi mixed at 2:1 ratio with vehicle or lysate 
to asses ER morphology. Scale bar: 5 µm. (E) Transgenic animals expressing hsp-4p::GFP grown 
on Empty Vector or let-767 RNAi combined with Empty Vector or sec-11 RNAi mixed with lysate 
to assess UPRER induction. RNAi mixed 1:1:1 ratio with vehicle or crude lysate. Images for 
transcriptional reporters contrast matched. Images for (C) and (D) contrasted enhanced 











Figure 4. Reduced lipid synthesis ameliorates let-767 knockdown defects in the UPRER 
induction  
(A) Transgenic animals expressing hsp-4p::GFP grown on Empty Vector or let-767/Control, 
sec-11/Control, sec-11/let-767 tandem RNAis mixed with Empty Vector or sbp-1 RNAi to asses 
UPRER induction. tdTomato sequence used as Control. Images contrast matched. (B) Lifespans 
of N2 animals grown on Empty Vector or let-767 RNAi combined with Empty Vector or sbp-1 
RNAi. (C-D) Concurrent survival assays of N2 animals transferred to ER stress conditions of 25 
ng/uL Tunicamycin (C) or control DMSO (D) conditions at day 1 of adulthood. Animals 
continuously grown on Empty Vector or let-767 RNAi combined with Empty Vector or sbp-1 
RNAi from L1 synchronization. (E) Transgenic animals expressing intestinal mCherry::HDEL 
or dhs-3::GFP grown on Empty Vector or let-767 RNAi combined with Empty Vector or sbp-1 
RNAi to asses ER and LD morphology. RNAi mixed with vehicle or lysate at 1:1:1: ratio. ER 
and LD images acquired and contrast enhanced individually to maximize organelle image 










Figure 5. let-767 mediated suppression of the UPRER through altered membrane dynamics 
(A) FRAP analysis of intestinal mRuby::HDEL ER marker of animals (n = 20) grown on Empty 
Vector or 50% let-767 RNAi supplemented with vehicle or crude lysate. (B) FRAP analysis of 
intestinal GFP::C34B2.10 ER marker of animals (n = 20) grown on Empty Vector or 50% let-
767 RNAi supplemented with vehicle or crude lysate. (C)  Transgenic animals expressing hsp-
4p::GFP grown on Empty Vector or sec-11 RNAi combined with Empty Vector, ire-1, or ire-1 
N-terminus RNAi to asses UPRER induction. (D) Transgenic animals expressing hsp-4p::GFP 
and intestinal mRuby::ire-1b grown on Empty Vector or sec-11 RNAi combined with Empty 
Vector, ire-1, or ire-1 N-terminus RNAi to asses UPRER induction. (E) Transgenic animals 
expressing hsp-4p::GFP and intestinal xbp-1s grown on Empty Vector or let-767 RNAi to asses 
UPRER induction. (F) Transgenic animals expressing hsp-4p::GFP and intestinal mRuby::ire-1b 
grown on Empty Vector or let-767 RNAi supplemented with vehicle or crude lysate to asses 
UPRER induction. All transcriptional reporter images contrast matched. Geometric mean ± SD 




Figure 6. Model for let-767 mediated suppression of the UPRER 
 
 
Figure 6. Model for let-767 mediated suppression of the UPRER 
(A) Under WT conditions, the ER produces lipids and lipid droplets, and responds to proteotoxic 
stress. let-767 knockdown results in accumulation of its toxic substrate, resulting in reduced 
UPRER signaling and lipid synthesis. Knockdown of sbp-1 to diminish lipid pathways upstream 




Chapter 4: Conclusions and Future Directions 
4.1 Conclusions 
 We have identified the sterol dehydrogenase, let-767, as an essential gene for ER lipid 
and protein homeostasis. As a central hub for lipid synthesis and protein trafficking, the ER must 
be able to monitor and respond to imbalances in both to preserve cellular function. This feat is 
accomplished by the three branches of the UPRER, each capable of monitoring both misfolded 
proteins and ER membrane changes[5], [26], [75]. 
 The ER must maintain lipid homeostasis in part, to preserve protein quality. The ER 
membrane composition must be controlled to provide environments that allow proper folding of 
transmembrane proteins, formation of transmembrane protein complexes, and translocation of 
nascent proteins [77]. Thus, it is no surprise that the UPRER responds to lipid changes that affect 
membrane quality such as phospholipid saturation and head group. Here, we find that 
knockdown of a steroid dehydrogenase, let-767, alters ER membrane qualities and global lipid 
metabolism, but does not instigate the UPRER. 
 Deficiencies in signaling and essential metabolites can often be compensated for by 
supplementation of the missing metabolites. For example, in C. elegans, addition of dafachronic 
acid or isoheptadecanoic acid to their food source prevents the phenotypes associated with 
mutations in those respective pathways. However, an inability to process metabolites can also 
result in toxic accumulation of metabolites, as in the cases of phenylketonuria or Zellweger 
syndrome, where phenylalanine or branched and very long chain fatty acids accumulate to toxic 
levels, respectively. In the case of let-767 knockdown, we see phenotypes that fall into both 
categories. Knockdown animals require lipid supplementation of normal growth, but also loss of 
lipogenic pathways to rescue ER membrane signaling of the UPRER. Whether the accumulation 
of the LET-767 metabolite disrupts the ER enough to affect global lipid metabolism or whether 
the LET-767 product is in fact needed to promote lipid synthesis, remains unclear. 
4.2 Future Directions 
 Changes in proteostasis contribute to aging, neurodegenerative disease, and metabolic 
disorders [9], [10]. While many of the major pathways monitoring proteostasis have been 
identified [5], we have yet to conclusively elucidate all the factors that impact these pathways. 
Our results bring to light the potential of the let-767 lipid pathway to negatively regulate 
proteostasis response mechanisms. The ER is composed of many lipids, each with their own 
characteristics that can affect membrane quality. Previous work implicates let-767 in both sterol 
and fatty acid metabolism; two lipid types known to affect membrane fluidity and function as 
signaling molecules [16], [62], [63]. Through biochemical analysis and further genetic screens, 
we may identify the specific lipid species and metabolic pathways of let-767 which mediate 
influence over the UPRER. 
 Within our model, we propose that accumulation of a metabolite alters membrane 
dynamics and leads to impaired ER function. In cases of aging and obesity, we see drastic 
changes in lipid metabolism [31]. Understanding whether these metabolic changes also result in 
altered membrane dynamics would provide a potential mechanism through which age and 
obesity related diseases may progress. For example, the ability to induce the UPRER has been 
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shown to decline during the aging process. This has been partly ascribed to diminished xbp-1 
signaling [13], a potential downstream result of decreased membrane dynamics and perturbations 
in IRE-1 oligomerization comparable to those of let-767 knockdown. Of interest, would be 
determining if any declines in membrane fluidity during the aging process are possibly due to 
reduced function of LET-767.  
 Increased UPRER signaling through ectopic expression of the activated form of xbp-1, 
xbp-1s, extends C. elegans lifespan and imbues increased proteotoxic stress survival [13]. During 
our investigation of let-767, we created a C. elegans strain ectopically expressing ire-1b, a 
possible isoform lacking the luminal unfolded protein sensing domain. While the luminal domain 
of IRE1 has been shown to be required for sensing proteotoxic stress and higher order oligomer 
formation, similarly truncated forms of IRE1have displayed increased basal UPRER and 
functional responsiveness to membrane lipid stress [25], [78], suggesting that the luminal domain 
is dispensable for some of its functions. In our hands, ectopic expression of ire-1a proved to be 
toxic, however, ire-1b animals appear phenotypically normal. Understanding how ire-1b 
signaling differs from ire-1a and whether it is also different from xbp-1s mediated activation of 
the UPRER would provide valuable insights on how chronic UPRER activation can contribute to 




Chapter 5: Appendix 
5.1 Improved proteotoxic stress resistance through ire-1 over-expression 
 ER homeostasis is monitored by three transmembrane proteins (IRE-1, PEK-1/PERK, 
ATF-6) capable of recognizing misfolded ER proteins and ER membrane disequilibrium. The 
most studied of these proteins, IRE-1, oligomerizes upon its activation and splices the xbp-1 
transcription factor mRNA to its more active isoform, xbp-1s. XPB-1S is then able to induce 
expression of key factors of the UPRER to restore ER homeostasis [5], [26], [27], [58]. Previous 
work has shown that ectopic activation of the UPRER through over-expression of xbp-1s can 
significantly improve survival of animals under proteotoxic stress and increase lifespan, likely 
through improved ER homeostasis [13]. Whether ectopic activation of the UPRER upstream of 
xbp-1 has similar improvements on lifespan and stress resistance has not been thoroughly 
investigated. 
 We have demonstrated that intestinal over-expression of ire-1 without the ER luminal 
domain (ire-1b) is sufficient to induce activation of the UPRER (Fig.5D). While the ire-1 luminal 
domain has been shown to be required for clustering of mammalian IRE1 in response to 
proteotoxic stress, it is dispensable for lipid mediated activation of the UPRER [25], [78]. 
Interestingly, over-expression of the full ire-1 (ire-1a) proved to be toxic during development 
(data not shown), implying a functional difference between UPRER induced by overexpression of 
ire-1a and ire-1b. Whether this difference is mechanistically distinct or a simply a difference in 
activation intensity remains to be determined; however, distinct functional outcomes between 
oligomeric states of ire-1 have been previously reported [79].  
Next, we tested whether over-expression of ire-1b is capable of increasing lifespan 
similar to xbp-1s over-expression. Our preliminary results suggest that ire-1b over-expression 
does not increase lifespan but is able to rescue the lifespan reduction caused by xbp-1 RNAi 
(Fig.S1A). A possible explanation of these results is that the over-expression of ire-1b increases 
effective splicing of xbp-1 to xbp-1s which is then able to compensate for the reduced levels of 
xbp-1 mRNA caused by RNAi. Alternatively, increased IRE-1 functions independent of xbp-1 
splicing (e.g. regulated Ire1-dependent decay) may be responsible for the restored lifespan of 
xbp-1 knockdown animals. Future lifespan analyses of xbp-1 knockouts will provide insight on 
whether the rescued lifespan is independent of xbp-1 splicing. 
We then performed an ER stress survival analysis on ire-1b over-expressing (OE) 
animals. Our preliminary analysis showed that ire-1b over-expression did not improve ER stress 
resistance, similar to lifespans (Fig.S1B-C). However, these results were confounded by a ~66-
70% censorship of ire-1b OE animals on tunicamycin treatment due to desiccation upon 
crawling up the sides of the plates (data not shown), compared to 15-18% censorship of N2 
animals on tunicamycin. Further analysis will determine whether ire-1b over-expression may 
impart avoidance behaviors to animals undergoing ER stress. Interestingly, during the stress 
survival assay, we observed that a small percentage of eggs laid by ire-1b OE animals on 
tunicamycin treatment were able to develop to adulthood, while 100% of N2 animals hatching on 
tunicamycin died during early development (Fig.S1D). These results suggest that while ire-1b 
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over-expression may not increase lifespan or long-term tunicamycin stress resistance, it did 
protect animals from lethal tunicamycin stress during development. 
Our preliminary results provide evidence that ire-1 over-expression induces the UPRER in 
a manner distinct from previously described induction of the UPRER through xbp-1s over-
expression [13]. While intestinal ire-1b OE animals did not display increases in lifespan or 
improved long-term ER stress resistance, ire-1b over-expression was nonetheless protective 
during development on tunicamycin induced ER stress. These contrasting results may be due to 
additional IRE-1 functions independent of xbp-1 splicing.  Furthermore, deletion of the ire-1a 
luminal domain was necessary to prevent lethal toxicity of ire-1 over-expression. This further 
highlights the distinction between xbp-1s and ire-1b overexpression regarding activation of the 
UPRER and organismal health, as xbp-1s OE does not appear to be toxic. With further 
investigation, we hope to provide insight on the unique roles that xbp-1 and ire-1 play in 
determining whether induction of the UPRER is beneficial or detrimental to stress resistance and 




5.2 Appendix figures 
 
Figure S1. Intestinal ire-1b over-expression does not increase lifespan, but improves 
development on tunicamycin 
 
Figure S1. Intestinal ire-1b over-expression does not increase lifespan, but improves 
development on tunicamycin 
(A) Lifespans of N2 or transgenic animals expressing vha-6p::mRuby::ire-1b grown on Empty 
Vector or xbp-1 RNAi. (B-C) Concurrent survival assays of N2 or transgenic animals expressing 
vha-6p::mRuby::ire-1b transferred to ER stress conditions of 25ng/uL Tunicamycin (B) or 
control DMSO (C) conditions at day 1 of adulthood. Animals continuously grown on Empty 
Vector or xbp-1 RNAi from L1 synchronization. (D) Day 5 N2 or transgenic animals expressing 
vha-6p::mRuby::ire-1b grown on Empty Vector with ER stress conditions of 25ng/uL 
Tunicamycin from hatch. White arrows denote dead animals. Black arrows denote animals 
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